Comparable outcomes with bortezomib-cyclophosphamide-dexamethasone (VCD) and bortezomib-lenalidomide-dexamethasone (VRD) for initial treatment of newly diagnosed multiple myeloma (MM)

 Article Details
Title: Comparable outcomes with bortezomib-cyclophosphamide-dexamethasone (VCD) and bortezomib-lenalidomide-dexamethasone (VRD) for initial treatment of newly diagnosed multiple myeloma (MM)
Dateline: 2013-12-07    DisplayDateline   
Byline: Kumar SK, Engebretson AE, Buadi FK, Lacy MQ, Dispenzieri A, Sheng Duh M, Lafeuille M, Lefebvre P, Cheng W, Dea K, Yap M, Saravanan S, Rembert D, Patt D, Niculescu L, Ba-Mancini A, Ma E, Rajkumar SV
Publication Title:
CTA Link: https://ashpublications.org/blood/article/122/21/3178/12305/Comparable-Outcomes-With-Bortezomib
CTA Text: Read More
Filter(s):*
This creates the tags that filter the listing page by specific taxonomies that display to the right of the main content and read more link.
  • Filter Title - NOT NEEDED
  • Filter Taxonomies - displays the actual filter tag within the item on the listing page.
    (must match the tagging on the Categories Tab in this Smart Form)
  • Filter Link - NOT NEEDED
  • Exclude from tagging - NOT NEEDED
Filters
Filter Title:  
Filter Taxonomies:
  1. Breadcrumb:  All Tumor Types

    Category: ( What's This?)

    Articles: ( What's This?)
Filter Link:   
Exclude from tagging:   

top